Press Releases
October 24, 2002
Debiopharm S.A. licenses-in new technology to turn injectable macromolecular drugs into oral formulations
August 19, 2002
Media Alert: successful registration after shortest ever review by the FDA of Eloxatin
July 15, 2002
Dyax Corp. and Debiopharm S.A. report successful results of phase IIA clinical trial with DX-890 for cystic fibrosis
June 27, 2002
Debiopharm S.A. inaugurates a new State-of-the-Art Galenic Unit in Gland, Switzerland
June 21, 2002
H3 Pharma announces promising developments for the treatment of Alzheimer´s disease
May 14, 2002
Debiopharm S.A. reports study revealing that EPI-HNE4 offers protection against acute lung injury
March 24, 2002
Debiopharm SA a acquis un nouveau bâtiment à Lausanne et projette de déménager vers la fin 2004